ASHLEY CORTES: Open Payments
NPI 1346842887 · NEW SMYRNA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,472 in 74 payments from 19 companies in 2025. Trend: 2023 $1,142 · 2024 $1,306 · 2025 $1,472
Food & beverage: $1,472
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 25 | $416 |
| Regeneron Healthcare Solutions, Inc. | 12 | $316 |
| Amgen Inc. | 6 | $102 |
| GENZYME CORPORATION | 4 | $86 |
| Mallinckrodt Hospital Products Inc. | 3 | $67 |
| AstraZeneca Pharmaceuticals LP | 4 | $63 |
| Viatris Specialty LLC | 3 | $60 |
| Insmed, Inc. | 2 | $48 |
| Pulmonx Corporation | 2 | $43 |
| Merck Sharp & Dohme LLC | 2 | $42 |
Products named: DUPIXENT, TRELEGY ELLIPTA, NUCALA, TEZSPIRE, ACTHAR, YUPELRI, Arikayce, CHARTIS CATHETER.
Industry payments across FL — which companies pay providers there.
